Review Article
, -Dimethylphenylalanine : A Useful Aromatic Amino Acid Surrogate for Tyr or Phe Residue in Opioid Peptides
Table 6
Opioid receptor-binding affinity and biological activities of opioid peptide analogs containing Dmp at position 1.
| Peptide | Receptor binding affinity, . E. (nM) | | | GPI (μ) | MVD () | | | μ
a | | /μ | μ/ | IC50 (nM) | IC50 (nM) | MVD/GPI | GPI/MVD |
| Tyr-Gly-Gly-Phe-Leu (ENK) | 2.42 ± 0.93 | 1.43 ± 0.71 | — | 1.69 | 103 ± 30 | 22.2 ± 4.3 | — | 4.64 | ENK (32) | 5.94 ± 1.45 | 1.86 ± 0.61 | — | 3.19 | 710 ± 69 | 66.6 ± 12.7 | — | 10.66 | ENKc | 0.0068 ± 0.003 | 0.031 ± 0.011 | — | 0.22 | 0.55 ± 0.17 | 0.17 ± 0.02 | — | 3.24 | ENK (33) | 169 ± 12 | 73.7 ± 19.5 | — | 2.29 | | | — | — | Deltorphin II (DT) | 314 ± 53 | 0.0226 ± 0.0077 | — | 13894 | 5437 ± 812 | 0.582 ± 0.029 | — | 9342 | DT (34) | 156 ± 33 | 0.329 ± 0.077 | — | 475 | 4038 ± 1118 | 0.272 ± 0.054 | — | 14835 | DT (35) | | 1394 ± 495 | — | — | | 662 ± 147 | — | — | DT (36) | 0.261± 0.060 | 0.012 ± 0.002 | — | 21.8 | 88.4 ± 22.7 | 0.052 ± 0.007 | — | 1700 | DT (37) | | 2.68 ± 1.22 | — | — | | 10.4 ± 1.5 | — | — | Tyr-Pro-Phe-Phe-NH2 (EM2) | 0.557 ± 0.306 | 14,070 ± 3346 | 25260 | — | 10.5 ± 1.2 | 317 ± 65 | 30.2 | — | EM2 (38) | 2.48 ± 1.46 | 6762 ± 590 | 2727 | — | 76.9 ± 20.7 | 661± 316 | 8.61 | — | EM2 (39) | 40.4 ± 2.6 | 9714 ± 3820 | 241 | — | 1392 ± 221 | 2329 ± 943 | 167 | — | EM2d | 0.15 ± 0.04 | — | — | — | 0.07± 0.02 | 1.87 ± 0.61 | 26.7 | — | EM2 (40) | 54.1± 23.4 | 18,851 ± 10,487 | 348 | — | 1073 ± 309 | 5,199 ± 2,584 | 4.85 | — | Tyr-D-Arg-Phe-βAla-NH2 (YRFB) | 0.172 ± 0.025 | 482 ± 121 | 2802 | — | 531± 0.72 | 116 ± 18 | 21.8 | — | YRFB (24) | 0.0623 ± 0.0140 | 2572 ± 947 | 41284 | — | 9.88 ± 1.04 | 188 ± 52 | 19 | — | YRFB (41) | 7.62 ± 1.75 | | | — | 320 ± 30 | 1474 ± 283 | 4.6 | — | YRFB (25) | 0.0216 ± 0.0062 | 1688 ± 458 | 78148 | — | 2.76 ± 0.56 | 501 ± 86 | 18.2 | — | YRFBc | 0.00205 ± 0.00069 | 1.13 ± 0.13 | 551 | — | 0.034 ± 0.065 | 0.398 ± 0.085 | 11.7 | — | YRFB (42) | 7.17 ± 1.03 | | | — | 633 ± 89 | 7143 ± 950 | 11.2 | — |
|
|
aVersus [3H]DAMGO. bVersus [3H]DT. cData cited from [39]. dData cited from [29].
|